Synbiotic Health, Inc.

Synbiotic Health, Inc. is a leading innovator in the field of probiotics, specializing in the development and commercialization of advanced probiotic strains. Founded in 2018 by a team of microbiome researchers from the University of Nebraska-Lincoln, the company focuses on improving human health through its signature strain, iVS-1®, and other novel microbes. Synbiotic Health collaborates with global dietary supplement brands to enhance their formulations with targeted, ecologically-sourced biotics. Their research lab in Madison, Wisconsin, supports the development and optimization of these strains, ensuring high-quality and effective products. The company is committed to advancing gut health, healthy aging, and overall well-being through science-driven innovation.

The Nombase Funding database has 4,288 records from over 1,788 companies.

There's no funding data for this company.